Interview with Michael Pehl, Managing Director, Celgene Germany
Celgene is very new in the German market. What would you say have been the main achievements of Celgene Germany since its establishment in 2006? Celgene Germany started as a…
Address: Neuhauser Str. 47, D-80331 München,Germany
Tel: +49-(0)89-23 66 50-0
Conreso is a German contract research organization which has set a benchmark with its unequaled quality. Both national and international customers benefit from the exceptional efficiency, pleasantly fast pace and incomparable willingness to provide service.Satisfied customers reward Conreso with their loyalty. The repeat business quote was consistently 90% over the past ten years. With their highly qualified employees, Conreso combines the professional scientific expertise of an academic institute with the efficiency of a CRO.CRO Muenchen was founded in 1990 by Jürgen Schäfer, with the aim of conducting studies in Germany according to FDA standards, which was not considered to be standard practice in Europe at that time. After over 17 years, CRO Muenchen changes its name to Conreso.
Celgene is very new in the German market. What would you say have been the main achievements of Celgene Germany since its establishment in 2006? Celgene Germany started as a…
Could you briefly present the Association of German Biotechnology Companies (VBU) and DECHEMA e.V. to our readers and describe their importance to the German biotechnology industry? VBU is a non…
Hospira, which was spun-off from Abbott Laboratories in 2004, is a global specialty pharmaceutical and medication delivery company driven by its vision of Advancing Wellness™. Bringing proven leadership and experience,…
How challenging is for you as General Manager of Nycomed Germany to lead the number one subsidiary of the Nycomed Group and what would you highlight as the key milestones…
The acquisition of IVAX in 2006 was decisive to establish Teva as the number one generic producer worldwide and further consolidate the company in the German market; and this process…
Astellas has been present in the German market for almost two decades through Yamanouchi and Fujisawa. But since 2005 it gained a new identity thanks to the merger of the…
Cytonet is today Germany’s largest cell therapy enterprise. However, it went through many transformations since its spin-off from Roche Diagnostics in 2000. Could you briefly introduce the company to our…
The German Pharmaceutical Industry is not only known for its cutting-edge R&D and production base but also for having a high penetration of generics. In your opinion, what role do…
See our Cookie Privacy Policy Here
